Powder For Injection Omeprazole Sodium 40mg Indicated For Disorders Associated

Basic Information
Place of Origin: China
Brand Name: BBCA
Certification: GMP
Model Number: BBCA180022706
Price: Negotiated
Packaging Details: 10VialsX100Boxes/Carton
Delivery Time: 25 DAYS AFTER PAYMENT
Payment Terms: L/C, T/T, , MoneyGram, L/C, T/T, , MoneyGram
Place Of Origin: China (Mainland) Brand Name: BBCA
Other Names: Powder For Injection Made In China Omeprazole Sodium For Injection Grade: Medicine Grade
Dosage Form: Injection
High Light:

pantoprazole sodium sesquihydrate


heparin sodium injection

Powder For Injection Omeprazole Sodium 40mg Indicated For Disorders Associated

Product Description

Powder for Injection Made in China Omeprazole Sodium for Injection

Each vial contains:
Omeprazole equivalent to 40mg

Omeprazole is a substituted benzimidazole that suppresses gastric acid secretion by specific inhibition of the H'/K' ATP ase enzyme system (proton pump) at the secretory surface of the gastric parietal cell thus blocking the final step of acid production.

It is indicated for disorders associated with hypersecretion of gastric acid such as benign gastric ulcers, duodenal ulcers , gastroesophageal reflux disease and Zollinger-Ellison syndrome.

Hypersensitivity to the components of the formulation.

Warnings and Precautions
Drugs metabolised in the liver:
Omeprazole can prolong the elimination of diazepam , warfarin and phenytoin which are metabolised by oxidation in the liver.
Hence , at the time of concomitant administration , dosage adjustment should be done after careful monitoring of the patient.

Ketoconazole, ampicillin esters and iron salts : Because of its profound and long lasting inhibition of gastric acid secretion, omeprazole may interfere with the absorption of those drugs where gastric PH
is an important determinant of their bioavailability.

There are no adequate or well controlled studies of omeprazole in pregnancy. Hence a decision should be made by taking into account the benefits offered and the potential risk involved.

It is not known whether omeprazole is secreted in breast milk. But becasue of the potential for adverse effects , a decision should be made whether to discontinue nursing or to discontinue the drug, taking into
account the importance of the drug to mother.

Safety and effectiveness has not been established.

Symptomatic response to therapy with omeprazole does not preclude the presence of gastric malignancy.

Side Effects
Nausea , headache , diarrhoea , constipation and flatulence are reported but occur rarely. These events are mild and transient and there has been no consistent relationship with treatment.


Contact Details

Phone Number : +8618755119229

WhatsApp : +8615855122780